Related Experiment Video
Updated: Mar 19, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Stimulant Use Disorders.
Taryn M Park1, William F Haning1
1Department of Psychiatry, John A. Burns School of Medicine, University of Hawaii, 1356 Lusitana Street, 4th Floor, Honolulu, HI 96813, USA.
Stimulant use in adolescents, particularly methamphetamine, poses serious health risks due to ongoing brain development. Interventions must consider age-specific differences for effective prevention and treatment.
Area of Science:
- Neuroscience
- Adolescent Health
- Substance Abuse Research
Background:
- Stimulant misuse is a significant concern in adolescent populations, despite lower prevalence compared to other illicit drugs.
- Methamphetamine serves as a key model for understanding adolescent stimulant use, with cocaine and prescription stimulants also noted.
- Adolescent stimulant use presents serious health risks, including potential long-term physical, cognitive, and psychiatric damage.
Purpose of the Study:
- To highlight the dangers of stimulant use in adolescents, using methamphetamine as a primary example.
- To underscore the unique risks associated with adolescent stimulant consumption due to critical brain development stages.
- To emphasize the need for tailored interventions considering developmental differences between adolescents and young adults.
Main Methods:
- Review of existing literature on adolescent stimulant use.
- Analysis of methamphetamine as a model substance for stimulant effects in youth.
- Consideration of neurodevelopmental factors in adolescent substance abuse.
Main Results:
- Adolescent stimulant use, especially methamphetamine, carries severe physical, cognitive, and psychiatric consequences.
- The developing adolescent brain is uniquely vulnerable to the detrimental effects of stimulants.
- Risks of stimulant misuse are amplified in adolescents compared to adults due to neurodevelopmental factors.
Conclusions:
- Methamphetamine and other stimulant use in adolescents is a critical public health issue requiring focused attention.
- Interventions for adolescent stimulant use must account for the specific neurobiological and developmental characteristics of this age group.
- Recognizing the differences between adolescent and young adult populations is crucial for designing effective prevention and treatment strategies.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
10:28Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Stimulants: Psychedelic Agents